{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T01:14:42Z","timestamp":1769476482758,"version":"3.49.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Incubation fund of Shaanxi Provincial People's Hospital","award":["2023YJY-15"],"award-info":[{"award-number":["2023YJY-15"]}]},{"name":"the Science and Technology Talent Support Program of Shaanxi Provincial People's Hospital","award":["2023-G-001"],"award-info":[{"award-number":["2023-G-001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Recent studies have shown that tumor cell membranes exhibit lower polarity than normal cell membranes, a characteristic that can be harnessed for cancer diagnosis. TPAS (viscosity-responsive plasma membrane probe), a recently developed staining method using cell membrane polarity probes, may selectively visualize cervical cancer cells by targeting membrane polarity differences, offering a potential new approach for cervical cancer screening.To investigate the diagnostic value of TPAS staining combined with liquid-based thin-layer cytological testing (TCT) and human papillomavirus (HPV) testing in detecting cervical cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 100 patients with suspected cervical precancerous lesions from the People\u2019s Hospital of Shaanxi Province between May 2024 and May 2025 were studied. All patients underwent TPAS testing, HPV testing and TCT. Biopsy results were the gold standard for evaluating positivity rates and diagnostic values of the tests, both individually and in combination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among the 100 participants, the positive rates of the tests were as follows: TPAS detection rate was 86.7%, HPV detection rate was 80%, TCT rate 66.7%, and TCT\u2009+\u2009HPV rate was 35.00%. The combined TPAS\u2009+\u2009HPV testing showed higher accuracy (72.00%) and sensitivity(70.6%) than TCT\u2009+\u2009HPV (58.0%)and (54.1%), and the differences were statistically significant ((\u03c72\u2009=\u200914.00,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.0002).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>TPAS combined with HPV testing has high specificity, sensitivity and accuracy, making it a promising approach for cervical cancer diagnosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13000-025-01744-w","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T08:37:21Z","timestamp":1766392641000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Application value of TPAS staining technique for cervical exfoliated cells in cervical cancer screening"],"prefix":"10.1186","volume":"21","author":[{"given":"Guo","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuchen","family":"HuYan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yipching","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wensheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoqiang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zifan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"1744_CR1","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","volume":"8","author":"M Arbyn","year":"2020","unstructured":"Arbyn M, Weiderpass E, Bruni L, de Sanjos\u00e9 S, Saraiya M, Ferlay J, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8:e191\u2013203.","journal-title":"Lancet Glob Health"},{"key":"1744_CR2","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1038\/s41416-020-0790-1","volume":"122","author":"D Hashim","year":"2020","unstructured":"Hashim D, Enges\u00e6ter B, Baadstrand Skare G, Castle PE, Bj\u00f8rge T, Trop\u00e9 A, et al. Real-world data on cervical cancer risk stratification by cytology and HPV genotype to inform the management of HPV-positive women in routine cervical screening. Br J Cancer. 2020;122:1715\u201323.","journal-title":"Br J Cancer"},{"key":"1744_CR3","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011439","volume":"97","author":"H Yang","year":"2018","unstructured":"Yang H, Zhang X, Hao Z. The diagnostic accuracy of a real-time optoelectronic device in cervical cancer screening: a PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2018;97:e11439.","journal-title":"Medicine (Baltimore)"},{"key":"1744_CR4","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1158\/1055-9965.EPI-07-2922","volume":"17","author":"RP Insinga","year":"2008","unstructured":"Insinga RP, Liaw KL, Johnson LG, Madeleine MM. A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States. Cancer Epidemiol Biomarkers Prev. 2008;17:1611\u201322.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1744_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2024.127857","volume":"287","author":"R Huang","year":"2024","unstructured":"Huang R, Liu Z, Sun T, Zhu L. Cervicovaginal microbiome, high-risk HPV infection and cervical cancer: mechanisms and therapeutic potential. Microbiol Res. 2024;287:127857.","journal-title":"Microbiol Res"},{"key":"1744_CR6","first-page":"147","volume":"62","author":"D Saslow","year":"2012","unstructured":"Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin. 2012;62:147\u201372.","journal-title":"CA Cancer J Clin"},{"key":"1744_CR7","doi-asserted-by":"publisher","first-page":"4773","DOI":"10.2147\/CMAR.S197749","volume":"11","author":"D Pan","year":"2019","unstructured":"Pan D, Zhang CQ, Liang QL, Hong XC. An efficient method that combines the ThinPrep cytologic test with E6\/E7 mRNA testing for cervical cancer screening. Cancer Manag Res. 2019;11:4773\u201380.","journal-title":"Cancer Manag Res"},{"key":"1744_CR8","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1001\/jama.2023.13174","volume":"330","author":"RB Perkins","year":"2023","unstructured":"Perkins RB, Wentzensen N, Guido RS, Schiffman M. Cervical cancer screening: a review. JAMA. 2023;330:547\u201358.","journal-title":"JAMA"},{"key":"1744_CR9","doi-asserted-by":"publisher","first-page":"96","DOI":"10.23736\/S0026-4784.20.04511-6","volume":"72","author":"SA Pimple","year":"2020","unstructured":"Pimple SA, Mishra GA, Deodhar KK. Evidence based appropriate triage strategies for implementing high risk HPV as primary technology in cervical cancer screening. Minerva Ginecol. 2020;72:96\u2013105.","journal-title":"Minerva Ginecol"},{"key":"1744_CR10","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/ajcp\/aqw125","volume":"146","author":"TC Wright Jr","year":"2016","unstructured":"Wright TC Jr., Stoler MH, Aslam S, Behrens CM. Knowledge of patients\u2019 human papillomavirus status at the time of cytologic review significantly affects the performance of cervical cytology in the ATHENA study. Am J Clin Pathol. 2016;146:391\u20138.","journal-title":"Am J Clin Pathol"},{"key":"1744_CR11","doi-asserted-by":"publisher","first-page":"7254","DOI":"10.1021\/acs.analchem.3c00220","volume":"95","author":"Q Li","year":"2023","unstructured":"Li Q, Zhu W, Gong S, Jiang S, Feng G. Selective visualization of tumor cell membranes and tumors with a viscosity-sensitive plasma membrane probe. Anal Chem. 2023;95:7254\u201361.","journal-title":"Anal Chem"},{"key":"1744_CR12","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1159\/000506725","volume":"64","author":"KRM Leite","year":"2020","unstructured":"Leite KRM, Pimenta R, Canavez J, Canavez F, de Souza FR, Vara L, et al. HPV genotype prevalence and success of vaccination to prevent cervical cancer. Acta Cytol. 2020;64:420\u20134.","journal-title":"Acta Cytol"},{"key":"1744_CR13","unstructured":"World Health Organization. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention: use of dual-stain cytology to triage women after a positive test for human papillomavirus (HPV). Geneva: WHO; 2024. Available from: https:\/\/iris.who.int\/handle\/10665\/376036."},{"key":"1744_CR14","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/S0140-6736(24)01438-7","volume":"404","author":"M McCormack","year":"2024","unstructured":"McCormack M, Eminowicz G, Gallardo D, Diez P, Farrelly L, Kent C, et al. Induction chemotherapy followed by standard chemoradiotherapy versus standard chemoradiotherapy alone in patients with locally advanced cervical cancer (GCIG INTERLACE): an international, multicentre, randomised phase 3 trial. Lancet. 2024;404:1525\u201335.","journal-title":"Lancet"},{"key":"1744_CR15","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1007\/s00404-019-05078-z","volume":"299","author":"Y Dai","year":"2019","unstructured":"Dai Y, Wang L, Li D. Compare two different usages of FRD for detecting high-grade cervical lesions and invasive cancer. Arch Gynecol Obstet. 2019;299:1399\u2013404.","journal-title":"Arch Gynecol Obstet"},{"key":"1744_CR16","unstructured":"World Health Organization. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition. Geneva: WHO; 2021. Available from: https:\/\/iris.who.int\/handle\/10665\/342326."},{"key":"1744_CR17","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.46234\/ccdcw2022.217","volume":"4","author":"M Zhang","year":"2022","unstructured":"Zhang M, Zhong Y, Wang L, Bao H, Huang Z, Zhao Z, et al. Cervical cancer screening coverage - China, 2018\u20132019. China CDC Wkly. 2022;4:1077\u201382.","journal-title":"China CDC Wkly"},{"key":"1744_CR18","first-page":"58","volume":"30","author":"YN Mao","year":"2021","unstructured":"Mao YN, You ZX. Interpretation of the ASCCP 2019 consensus guidelines on the management of abnormal cervical cancer screening results. Mod Adv Obstet Gynecol. 2021;30:58\u201364.","journal-title":"Mod Adv Obstet Gynecol"},{"key":"1744_CR19","first-page":"101","volume":"34","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Wei LH. Interpretation of the CSCCP expert consensus on issues related to cervical cancer screening and abnormal management in China. J Pract Obstet Gynecol. 2018;34:101\u20134.","journal-title":"J Pract Obstet Gynecol"},{"key":"1744_CR20","first-page":"262","volume":"38","author":"L Yang","year":"2023","unstructured":"Yang L, Liu DP, Wang FF. Application of liquid-based cytology combined with colposcopy in cervical cancer screening. J North Sichuan Med Coll. 2023;38:262\u20134.","journal-title":"J North Sichuan Med Coll"},{"key":"1744_CR21","doi-asserted-by":"publisher","first-page":"761","DOI":"10.21037\/atm-22-1732","volume":"10","author":"T Li","year":"2022","unstructured":"Li T, Lai Y, Yuan J. The diagnostic accuracy of TCT\u2009+\u2009HPV-DNA for cervical cancer: systematic review and meta-analysis. Ann Transl Med. 2022;10:761.","journal-title":"Ann Transl Med"},{"key":"1744_CR22","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000026004","volume":"100","author":"YX Li","year":"2021","unstructured":"Li YX, Luo HX, Wang W, Wang Z, Zhao WH, Hao M. Diagnostic accuracy of novel folate receptor-mediated staining solution detection (FRD) for CIN2+: a systematic review and meta analysis. Medicine (Baltimore). 2021;100:e26004.","journal-title":"Medicine (Baltimore)"},{"key":"1744_CR23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000528532","volume":"67","author":"AM Hopp","year":"2023","unstructured":"Hopp AM, Puzyrenko A, Giorgadze T. Comprehensive review of anal cytology. Acta Cytol. 2023;67:185\u201394.","journal-title":"Acta Cytol"},{"key":"1744_CR24","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1158\/1055-9965.EPI-22-1041","volume":"32","author":"M Arbyn","year":"2023","unstructured":"Arbyn M, Costa S, Latsuzbaia A, Kellen E, Girogi Rossi P, Cocuzza CE, et al. HPV-based cervical cancer screening on self-samples in the Netherlands: challenges to reach women and test performance questions. Cancer Epidemiol Biomarkers Prev. 2023;32:159\u201363.","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-025-01744-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-025-01744-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-025-01744-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T14:54:34Z","timestamp":1769439274000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13000-025-01744-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1744"],"URL":"https:\/\/doi.org\/10.1186\/s13000-025-01744-w","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"7 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Medical Ethics Committee of Shaanxi Provincial People\u2019s Hospital approved the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}